CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT]

Similar documents
TB Intensive San Antonio, Texas

New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents

The Origin of Swine Flu

Jeffrey R. Starke, M.D. has the following disclosures to make:

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017

TB Intensive Tyler, Texas December 2-4, 2008

Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015

TB Nurse Case Management

TB in Corrections Phoenix, Arizona

Disclosures. Current Issues and Controversies in Child and Adolescent Tuberculosis 02/24/2016. NSTC 2016 Annual Meeting

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

Tuberculin Skin Testing

Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast

Contact Investigation and Prevention in the USA

TB Prevention Who and How to Screen

LATENT TUBERCULOSIS. Robert F. Tyree, MD

Tuberculosis Tools: A Clinical Update

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

TB Update: March 2012

Diagnosis Latent Tuberculosis. Disclosures. Case

Tuberculosis Update. Topics to be Addressed

TB Intensive Houston, Texas October 15-17, 2013

TB Intensive San Antonio, Texas November 11 14, 2014

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014

Northwestern Polytechnic University

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

Fundamentals of Tuberculosis (TB)

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Management of Pediatric Tuberculosis in New Jersey

Tuberculosis (TB) Fundamentals for School Nurses

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University

Latent TB Infection (LTBI) Strategies for Detection and Management

Tuberculosis Populations at Risk

These recommendations will remain in effect until the national shortage of PPD solution has abated.

Tuberculosis Education for the Medical Professional

Approaches to LTBI Diagnosis

Michael J. Huey, MD. NYSCHA Annual Meeting WE-2, October 19, 2016

2017/2018 Annual Volunteer Tuberculosis Notice

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

Evaluation and Management of the Patient with Latent Tuberculosis Infection (LTBI)

Santa Clara County Tuberculosis Screening Requirement for School Entrance Effective June 1, 2014

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers

Peggy Leslie-Smith, RN

Latent Tuberculosis Best Practices

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

Programmatic management of LTBI : a two pronged approach for ending the TB epidemic. Haileyesus Getahun Global TB Programme WHO/HQ

Testing for Tuberculosis Infection and Disease: The Expanding Role of Blood-based Assays

Using Interferon Gamma Release Assays for Diagnosis of TB Infection

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

Please distribute a copy of this information to each provider in your organization.

Contact Follow-Up and Treatment of LTBI in Households of Infectious Cases in Pakistan

The Most Widely Misunderstood Test of All

Didactic Series. Latent TB Infection in HIV Infection

Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

Didactic Series. Latent TB Infection in HIV Infection

Tuberculosis Screening Protocol For Use In Marin County School Settings

Pediatric TB Updates, Tools, and Adorable Faces

Advanced Concepts in Pediatric Tuberculosis

Self-Study Modules on Tuberculosis

Latent TB Infection (LTBI)

Making the Diagnosis of Tuberculosis

Latent Tuberculosis in Adults: From Testing TO Treatment

11/1/2017. Disclosures. Update In Tuberculosis, Indiana Outline/Objectives. Pathogenesis of M.tb Global/U.S. TB Burden, 2016

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

Screening for Tuberculosis Infection. Harlingen, TX. Linda Dooley, MD has the following disclosures to make:

Tuberculosis Screening and Targeted Testing of College and University Students: Developing a Best Practice Approach:

Disclosures. Updates in TB for the PCP: Opportunities for Prevention. Objectives PART 1: WHY TEST? 4/14/2016. None

Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014

Director, University Health Services. Medical Director

Therapy for Latent Tuberculosis Infection

Advanced Concepts in Pediatric TB: Latent TB Infection

Tuberculosis in Children and Adolescents 2017

Diagnosis and Management of Latent TB Infection Douglas Hornick, MD September 27, 2011

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

ATTACHMENT 2. New Jersey Department of Health Tuberculosis Program FREQUENTLY ASKED QUESTIONS

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Contracts Carla Chee, MHS May 8, 2012

Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination

TB Transmission, Pathogenesis & Infection Control

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program

LATENT TUBERCULOSIS SCREENING AND TREATMENT:

TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014

Primer on Tuberculosis (TB) in the United States

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

Tuberculosis: Where Are We Now?

Latent tuberculosis infection

Community pharmacy-based tuberculosis skin testing

Latent TB, TB and the Role of the Health Department

Diagnosis and Medical Management of Latent TB Infection

ESCMID Online Lecture Library. by author

Screening and management of latent TB Infection Gerry Davies

Diagnosis and Medical Case Management of Latent TB. Bryan Rock, MD April 27, 2010

Tuberculosis. WRAIR- GEIS 'Operational Clinical Infectious Disease' Course UNCLASSIFIED

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Tuberculosis in Children Jeffrey R. Starke, MD October 9, 2008

Transcription:

CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT] QUESTION: : Which children in the United States should get a tuberculin skin test? Do questionnaires really work? Jeffrey R. Starke, M.D. Professor and Vice-Chairman of Pediatrics Baylor College of Medicine TUBERCULOSIS CASES IN THE UNITED STATES CHILDREN 0-14 YEARS OLD SOME REASONS WHY TUBERCULOSIS RESURGED IN THE U.S. 1984-92 92 1,800 1,600 1,400 1,200 1,000 800 600 400 200 0 1980 2000 HIV co-epidemic Immigration and visitation Transmission in congregate settings Poor tuberculosis control IMMIGRATION-RELATED RELATED TUBERCULOSIS IN THE UNITED STATES IMMIGRATION AND PEDIATRIC TUBERCULOSIS About 1 million annual legal immigrants 30-40% have latent tuberculosis infection (LTBI) Pool of infected individuals increases by 300-400K per year 2% - 5% risk of disease: 6,000 20,000 future cases per year Immigrants > 15 years old CXR only Immigrants < 15 years old no services Visitors, all ages no services California study: receipt of foreign visitors in the home was an independent risk factor for LTBI in a child

MANTOUX TUBERCULIN SKIN TEST uses 5 TU of purified protein derivative (PPD) interpret in 48 72 hours record size of induration in mm if it makes a reaction at >72 hrs, it counts! false negatives: 10% to 20% in disease TUBERCULIN SKIN TEST PROBLEMS CREATED BY FALSE POSITIVE TUBERCULIN SKIN TEST RESULTS Assume sensitivity = specificity = 95% When the prevalence of infection is 90%, the positive predictive value is 99% When the prevalence of infection is 1%, the positive predictive value is 15% [85% false positives] 1. There is no way to distinguish false from true positive results, so all positives should be evaluated and treated 2. Costs of evaluation: doctor/clinic time, xrays, medications, adverse reactions, evaluation of family members 3. Anxiety who has TB??? TUBERCULIN SKIN TEST UTILITY INDURATION SIZE POSITIVE TUBERCULIN SKIN TEST > 5 mm > 10 mm Accurate and useful for high-risk persons Inaccurate and, perhaps, harmful for low-risk persons HIV co-infection Foreign-born from a HR Immune compromise country Recent contact to TB Drug users Suspected disease Living in HR congregate setting Specific HR groups Children < 4 yrs old (AAP) >15 mm No risk factors

NYCDOH QUESTIONNAIRE FOR LTBI - RESULTS TARGETED TST TESTING KAISER PERMANENTE GROUP 23/413 (5.6%) of children with at least one risk factor had a reactive TST 4/2507 (0.16%) of children with no risk factors had a reactive TST ¾ children not identified were > 11years old 33,553 children in 18 offices Validated Risk Factors : Any Child Who was born outside the United States received a BCG vaccine lived outside the United States lives with someone with TB history LTBI RISK ASSESSMENT QUESTIONNAIRE FOR CHILDREN All risk assessment questionnaire should ask: QUESTION: : Should I repeat the TST when the result is borderline? 1. Was your child born outside the U.S? Where? 2. Has your child traveled (non-tourist, 1 wk) outside the U.S.? Where? 3. Has your child been in contact with anyone with TB? 4. Does your child have contact with anyone with a positive tuberculin skin test? REPEATING THE TST The TST does not get more accurate as one repeats it; it is more difficult to interpret Boosting: : tendency for increased induration with serial TSTs; ; in children, most often associated with previous receipt of a BCG vaccine The most accurate TST is the first one: do it right and do it well! CDC definition of a conversion of a TST is an increase in induration of 10 mm QUESTION: : Should I repeat the TST if the child has risk factors for LTBI?

HOW OFTEN SHOULD A TST BE GIVEN? Must separate previous risk from on-going risk Receipt of foreign visitors from high prevalence countries into the home was a risk factor for one California study for a positive TST in a child Frequent problem: summer trips abroad Sharing the air with indigenous people. For foreign travel, wait 3 months until after return QUESTION: : What really is the effect of a previous BCG vaccination on a subsequent TST? INTERACTION OF BCG VACCINES WITH THE TUBERCULIN SKIN TEST 50% of vaccinated infants do not react to a TST; most of the rest stop reacting within 5 years most non-infants who get one or more BCG vaccinations will react to a TST (usually < 15 mm), but effect wanes over 5 10 years outside infancy, positive TST more likely to indicate infection with M. tuberculosis than be residual from BCG QUESTION: : How do I handle tuberculin skin testing of foreign-born adopted children? TUBERCULIN SKIN TESTING OF FOREIGN-BORN ADOPTEES On one hand, most children have received a BCG vaccine within the past year, which can cause reaction to a TST On the other hand, many have lived in conditions conducive to transmission of M. tuberculosis and we can t t do an investigation

TUBERCULIN SKIN TESTING OF FOREIGN-BORN ADOPTEES General Guidelines 1. Assess for symptoms of tuberculosis disease prolonged (>2 wk) cough, weight loss, fevers QUESTION: : Should I (or someone) do a TST on family members of children who have a positive TST? 2. Note a BCG scar and/or immunization records 3. Place and read a 5 TU TST without controls 4. Delay the TST if the child is significantly malnourished 5. Positive TST reaction is 10mm, though this will result in some overtreatment due to recent BCG vaccination 6. Treat LTBI with isoniazid unless specific evidence of INH- resistance is uncovered ASSOCIATE INVESTIGATION CHILDREN WITH LTBI Associate investigation: identification and evaluation of close contacts of children and adolescent with LTBI can be considered a form of targeted testing although often recommended (AAP-Red Book), many health departments have limited/no resources yield of finding cases of tuberculosis is low yield of finding LTBI is 30% to 40% effective only if index child was tested because of risk QUESTION: : Is there any role currently for the new interferon-gamma release assays in diagnosing LTBI in infants and children? INTERFERON-GAMMA RELEASE FOR DIAGNOSIS OF LTBI IN CHILDREN - SEPTEMBER, 2006 Only commercially available (5/05) test in the U.S. is QuantiFERON-TB Gold Measures release of interferon-gamma into whole blood after stimulation of lymphocytes with ESAT-6 6 and CFP-10, proteins fairly specific for M. tuberculosis Unfortunately, data for children ware very limited. Despite this, CDC (12/05) states tests can be used in children.

Comparison of Tuberculin Skin Test and Interferon- ٢ Release Assays Antigens studied Cross-reactivity reactivity with BCG Cross-reactivity reactivity with NTM Estimated sensitivity, TB in immunocompetent adults Estimated specificity, TB in immunocompetent adults Distinguish between TB infection and TB disease Boosting No. of patient visits required Tuberculin Skin Test Many -PPD Yes Yes 75-90% 70-95% No Yes Two IFN- ٢ Release Assay ESAT-6, CFP-10 Unlikely Less Likely 75-95% 90-100% No No One QUESTION: : What are some pearls for treatment for LTBI in infants and children? TREATMENT OF LTBI IN CHILDREN 9 months of isoniazid (daily or twice weekly under DOT) is only accepted regimen INH-resistance or intolerance rifampin for 6 months Multidrug-resistance resistance consult an expert Use isoniazid unless there is documented exposure to a specific case of drug-resistant resistant TB PEARLS OF WISDOM FOR TREATING LTBI IN CHILDREN Use INH suspension only in children 5 kg Compliance with 9 months of INH averages 50% - be vigilant and skeptical Use DOPT for: recent contacts, infants, immune compromised When children aren t t tolerating INH, the problem is more often with the parent than the child Route LFTs only for: other liver toxic drugs, liver disease, signs or symptoms of hepatitis